Sort
51,593 grants matching “hepatitis”
Glucagon secretion and action in humans
$520,452Adrian Vella · Mayo Clinic Rochester · R01 · FY2023 · DK
Glucagon secretion and action in humans
$520,452Adrian Vella · Mayo Clinic Rochester · R01 · FY2022 · DK
Glucagon secretion and action in humans
$520,452Adrian Vella · Mayo Clinic Rochester · R01 · FY2025 · DK
Clinical Research on Nonalcoholic Fatty Liver Disease
$520,416Joel Edward Lavine · Columbia University Health Sciences · U01 · FY2010 · DK
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-tissue Metabolism
$520,376Graeme F Mason · Yale University · R01 · FY2018 · DK
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-tissue Metabolism
$520,376Graeme F Mason · Yale University · R01 · FY2016 · DK
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-tissue Metabolism
$520,376Graeme F Mason · Yale University · R01 · FY2017 · DK
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-tissue Metabolism
$520,376Graeme F Mason · Yale University · R01 · FY2019 · DK
Race - adiposity interactions regulate mechanisms determining insulin sensitivity
$520,333Barbara A. Gower · University Of Alabama At Birmingham · R01 · FY2016 · DK
Glycosylation Mutants of Mice and Animal Cells
$520,266Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2009 · CA
Alcohol and intestinal microvascular endothelium-immune axis and the role of gut derived immune nutrients
$520,191Gail Ann Cresci · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · AA
Normalized functional MRI in human brain disorders
$520,175Hanzhang Lu · Johns Hopkins University · R01 · FY2016 · MH
MODELING OF HOST IMMUNE RESPONSES AND ANTIVIRAL THERAPY AGAINST HEPATITIS C
$520,120Harel Dahari · University Of New Mexico · P20 · FY2010 · RR
Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver disease
$520,062Wenke Feng · Tulane University Of Louisiana · R01 · FY2025 · AA
Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver disease
$520,062Wenke Feng · Tulane University Of Louisiana · R01 · FY2024 · AA
Development of a Multiscale Mechanistic Simulation of Acetaminophen Induced Liver
$520,040James Alexander Glazier · Trustees Of Indiana University · U01 · FY2016 · GM
Roles of peroxisomal dysfunction in alcohol-related liver disease
$520,037Wei Zhong · University Of Kansas Medical Center · R01 · FY2025 · AA
SF Bay Area MACS/WIHS Combined Cohort Study
$519,977Phyllis C Tien · University Of California, San Francisco · U01 · FY2020 · HL
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
$519,971Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2020 · DK
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
$519,971Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2021 · DK
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
$519,971Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2022 · DK
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
$519,971Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2019 · DK
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
$519,964Timothy F Osborne · Johns Hopkins University · R01 · FY2022 · DK
Active, Enhanced Surveillance for Viral Hepatitis in San Francisco, California
$519,945Melissa Sanchez · San Francisco Department Of Public Health · U51 · FY2014 · PS
Active, Enhanced Surveillance for Viral Hepatitis in San Francisco, California
$519,945Melissa Sanchez · San Francisco Department Of Public Health · U51 · FY2015 · PS